US President Donald Trump has announced a new step to reduce the cost of medicines and health insurance. On Friday, he revealed “Most Favored Nation” pricing deals with nine more pharmaceutical companies. The goal is to make prescription drugs more affordable for Americans.
Under this approach, drug prices in the US would be closer to the lowest prices paid by other developed countries. Trump praised the drug company leaders who joined him at the White House and said these agreements show progress in controlling high medicine costs. The deals are voluntary, but Trump described them as a positive move for patients.
Along with drug prices, Trump also turned his focus to health insurance premiums. He announced plans to hold a meeting with health insurers next week or in early January. During this meeting, he plans to push companies to lower insurance costs, which have been rising sharply.
Health insurance has become a major concern, especially for people who buy coverage through the Affordable Care Act (ACA) exchanges. Premiums are expected to increase even more as enhanced government subsidies are set to expire at the end of the year. This situation has added pressure on Republicans to find quick solutions.
Insurance companies say they are ready to cooperate. The Blue Cross Blue Shield Association said it is eager to work with Trump and Congress to bring down healthcare costs. In a statement, senior vice president David Merritt said Americans are frustrated with rising premiums and out-of-pocket expenses. He added that insurers are focused on fixing the main reasons behind these increases.
Trump said lowering healthcare costs remains a top priority. He believes cooperation between the government, insurers, and drug companies can help ease the financial burden on families.
While challenges remain, these new talks and pricing deals signal renewed efforts to make healthcare more affordable for millions of Americans.